SCIENTURE HOLDINGS INC (SCNX)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
$0.37+0.87%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
QuarterlyIQ Insights · SCNX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | — | 0.4 | 0.1 | 1.4 | 10.3 | 9.9 | 17.1 | 7.4 | 3.8 | — | 2.5 | 2.9 | 1.5 |
| Total Revenues | — | — | — | — | — | — | — | — | 3.8 | — | 2.5 | 2.9 | 1.5 |
| Cost of Revenues | — | 0.1 | 0.1 | 1.3 | 4.7 | 5.1 | 11.4 | 2.6 | 0.4 | — | — | — | — |
| Gross Profit | — | 0.3 | 0.0 | 0.0 | 5.5 | 4.7 | 5.7 | 4.9 | 3.4 | 2.9 | 2.5 | 2.7 | 1.1 |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 2.5 | 2.0 | 2.2 | — | — | — | — | — | — | — | — | — | — |
| Operating Income | (40.1) | (42.6) | (14.7) | (4.4) | (2.9) | (5.3) | (2.5) | 0.1 | (0.1) | 0.4 | (1.0) | (0.1) | (1.4) |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | 4.1 | 1.3 | 1.2 | 0.3 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 |
| Other Non-Operating Income / Expenses | 0.1 | (0.9) | (4.1) | (4.1) | 0.5 | (0.0) | — | — | — | — | — | — | — |
| Asset Writedown | — | 26.3 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (43.5) | (18.8) | (8.5) | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | (2.0) | (0.5) | — | — | — | — | — | — | — | — | — | — |
| Earnings from Continuing Operations | — | (41.5) | (18.2) | (8.5) | — | — | — | — | — | 0.3 | — | — | — |
| Net Income | |||||||||||||
| Minority Interest | — | — | — | — | (0.4) | — | — | — | — | — | — | — | — |
| Net Income | (38.0) | (41.5) | 9.1 | (17.8) | (3.5) | (5.3) | (2.5) | (0.3) | 0.0 | 0.3 | (2.8) | (1.1) | (2.0) |
| Per Share | |||||||||||||
| Basic EPS | (0.96) | (2.70) | 2.69 | (23.35) | (6.15) | (0.65) | — | (0.05) | 0.00 | 0.01 | — | (0.04) | (0.07) |
| Diluted EPS | (0.96) | (2.70) | 2.48 | (23.35) | (6.13) | (0.65) | — | (0.05) | 0.00 | 0.01 | — | (0.04) | (0.07) |
| Basic Weighted Avg Shares | 39.6 | 15.3 | 3.4 | 0.8 | 0.6 | 8.1 | — | 5.9 | 5.4 | 32.0 | — | 31.3 | 29.8 |
| Diluted Weighted Avg Shares | 39.6 | 15.3 | 3.7 | 2.4 | 0.6 | — | — | 5.9 | 5.8 | 34.1 | — | 31.3 | 29.8 |
| Supplemental | |||||||||||||
| EBITDA | — | (42.1) | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | (40.1) | (42.6) | (14.7) | (4.4) | (2.9) | (5.3) | (2.5) | 0.1 | (0.1) | 0.4 | (1.0) | (0.1) | (1.4) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.